What will treatment look like?
The purpose of this study is to compare traditional cognitive behavioral therapy (CBT) with a new form of CBT that includes scenario rescripting. This latter treatment focuses on increasing empowerment and agency. Research participants in this study will be randomly assigned (similar to a coin flip) to receive either of the two treatments. In addition, all participants will be randomized to receive d-cycloserine or a placebo pill. D-cycloserine is an antibiotic medication (prescribed in very low doses in the current study) that may enhance learning during therapy.
The CBT (therapy) sessions are conducted by qualified therapists. The treatment consists of 4 weekly sessions (2 hours each), as well as assigned activities in between sessions that offer the opportunity to solidify the knowledge learned in session on your own time. The sessions can be arranged at a time that is convenient.
The study consists of 5 weekly visit, plus two follow-up assessments 1 week and 1 month after the end of the treatment. Each study visit will take up to two hours, and will take place in our clinic at Boston University.